Business
AstraZeneca vaccine approved for use in Australia, CSL (ASX:CSL) share price up
The CSL Limited (ASX: CSL) share price climbed 2% today after the AstraZeneca – Oxford University COVID-19 vaccine was approved for use in Australia.
According to reporting by the Australian Financial Review, the provisional approval will mean that adults who are 18 or older will be able to take two doses of the drug, between four to twelve weeks apart.
The Australian federal government has ordered almost 54 million doses of the vaccine, with CSL to start manufacturing within the country from the end of next month. CSL has been tasked with manufacturing 50 million doses.
One of the main benefits of the Oxford University – AstraZeneca COVID-19 vaccine is that it can be held in normal refrigerators. The Pfizer COVID-19 vaccine…
-
Noosa News20 hours agoBroncos’ Adam Reynolds confident of NRL finals return, Raiders’ Josh Papalii injured
-
Noosa News21 hours agoRiverfire spectators face crowd crushes, huge delays on trains and buses
-
Noosa News23 hours agoBig Brother’s Mike Goldman reveals what saved his life after waking up to find Brisbane home engulfed in fire
-
Business23 hours agoWhy is the Super Retail share price tumbling today?